Conference
A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies.
Authors
Crowther MA; Ginsberg JS; Gent M; Julian J; Costantini L; Kovacs M; Laskin C; Denburg JA; Fortin P; Clarke A
Volume
100
Pagination
pp. 148A-148A
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2002
Name of conference
44th Annual Meeting of the American-Society-of-Hematology
Conference place
PHILADELPHIA, PENNSYLVANIA
Conference start date
December 6, 2002
Conference end date
December 10, 2002
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971